... randomized study comparing breast- conserving surgery with radical mastectomy forearlybreastcancer N Engl J Med 2002, 347:1227-1232 Morrow M: Rational local therapy forbreastcancer N Engl J Med ... multicenter APBI trials for select early- stagebreastcancer were recently reported [8-10,15] In the RTOG phase II trial [9], 66 patients received HDR brachytherapy (34 Gy in 3.4 Gy bid for days) and 33 ... toxicity after accelerated partial -breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early- stagebreast carcinoma Cancer 2006, 106:991-999 doi:...
... intensitymodulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy forearlystage larynx cancer Radiation Oncology 2010 5:74 Submit your next manuscript to BioMed ... the plan The beam arrangement for the 3D and IMRT plans was the same as those used for treatment However, for consistency, the plans were re-optimized to all conform to the same constraints All ... dose) compared to any other plan Discussion Earlystage glottic cancer is a highly curable malignancy which can be treated with either larynx sparing surgery (laser excision, cordectomy, or hemilaryngectomy)...
... of the earlystagebreastcancer group This finding suggested that the multi-component cancer classifier described above might be potentially applicable forearly detection of breast cancer, ... which had putative diagnostic value forbreast cancer, especially at advanced clinical stages, yet none of them was routinely used forearly diagnostics of breastcancer [55-60] The plasma levels ... proteome patterns specific for healthy persons and breastcancer patients At first we compared the serum proteome patterns of 104 healthy women and 92 earlystagebreastcancer patients Spectral...
... analysis in diagnostics of breastcancer These works identified serum (or plasma) proteome patterns specific for patients with breastcancer at either early or late clinical stages [19-29] Different ... that were related to therapy of earlybreastcancer patients Methods Characteristics of patient groups Seventy patients diagnosed with clinical stage I or II breastcancer were included in our study, ... treatment of breastcancer patients In this pilot study [20], 16 paired serum samples collected from breastcancer patients before the treatment and posttreatment (6-12 months after surgery and...
... therapy versus conventional postoperative whole -breast radiotherapy after breast- conserving surgeryfor the management of early- stage invasive breastcancer (a trial update) Amer J Surg 2007, 194:507-510 ... clinical efficacy and safety for patients with early- stagebreastcancer Abbreviations BCT: Breast conserving therapy; EBRT: External beam radiation; APBI: Accelerated partial breast irradiation; MS: ... Marubini E: Twenty-year follow-up of a randomized study comparing breast- conserving surgery with radical mastectomy forearlybreastcancer N Engl J Med 2002, 347:1227-1232 Fisher B, Anderson S,...
... patients with earlystage disease, without overt metastasis, is still under investigation Figure cancer free Disease survival for 56 patients with earlystagebreast Disease free survival for 56 patients ... expression based markers for the detection of breastcancer cells BreastCancer Res Treat 2006, 97:41-47 Zach O, Lutz D: Mammaglobin remains a useful marker for the detection of breastcancer cells in ... patients with earlystagebreastcancer Comparing patients positive for RT-PCR markers (2 or more) with patients negative for RT-PCR markers (0 or 1) Page of 11 (page number not for citation purposes)...
... quantification platform to compare plasma proteins from earlystage (stage I and stage II) breastcancer patients in order to identify biomarkers forearly detection of breastcancer Using a large ... selected for estimating the breastcancer biomarker candidates 29 Line 1: ITGA5 → FN1 → IGFBP3 → IGF → TP53 → BreastCancer Line 2: SHC1 → IGF → TP53 → BreastCancer Line 3: TP53 → ESR1 → TSC2 → Breast ... Guihong Qi Biomarker Discovery in EarlyStageBreastCancer Using Proteomics Technologies Among women in the United State, breastcancer is the most common cancer diagnosed in women with approximately...
... life SurgerySurgery is a treatment choice for men with early- stage prostate cancer who are in good health Surgery to remove the prostate is called prostatectomy There are different types of surgery ... role in treating early- stage prostate cancerFor men with high-risk early- stage prostate cancer, it may be used along with radiation therapy You can also receive it instead of surgery or radiation ... -62 37 ) Facts About Prostate Cancer Early- stage prostate cancer means that cancer cells are found only in your prostate Compared with many other cancers, prostate cancer grows slowly This means...
... with early- stagebreastcancer in a randomized trial of adjuvant tamoxifen The Stockholm BreastCancer Study Group J Natl Cancer Inst 1993;85:1398–406 (49) McDonald CC, Alexander FE, Whyte BW, Forrest ... eligible for tamoxifen The decision relative to which of these women should or should not receive tamoxifen forbreastcancer prevention is complex The primary determinant for making such a decision ... Not at risk forbreast cancer* Without follow-up Included in analysis Average follow-up time, mo Median follow-up time, mo % followed for >36 mo % followed for >48 mo % followed for >60 mo Person-years...
... supraclavicular lymph node Diagnosis of breastcancer 15 Stage grouping Stage 0: Stage I: Stage IIa: Stage IIb: Stage IIIa: Stage IIIb: Stage IIIc: Stage IV: Tis, T1, T0, T1, T2, T2, T3, T0, ... treatment of earlystage invasive breastcancer including surgery, adjuvant therapy for nodenegative and node-positive breast cancer, primary chemotherapy in locally-advanced breast cancer, the ... in most cases Figures 1, and give treatment guidelines forearlystage invasive breast cancer, node-negative breastcancer and node-positive breast cancer, respectively Role of primary chemotherapy...
... decisions in axillary node-negative breastcancer Annu Rev Med 1993, 44:201-210 Polychemotherapy forearlybreast cancer: an overview of the randomised trials EarlyBreastCancer Trialists’ Collaborative ... Predictive and prognostic markers for invasive breastcancer Pathol Int 2002, 52:186-194 Cianfrocca M, Goldstein LJ: Prognostic and predictive factors in earlystage breastcancer Oncologist 2004, 9:606-616 ... Trialists’ Collaborative Group Lancet 1998, 352:930-942 Tamoxifen forearlybreast cancer: an overview of the randomised trials EarlyBreastCancer Trialists’ Collaborative Group Lancet 1998, 351:1451-1467...
... conservatively managed triple negative early- stagebreastcancer J Clin Oncol 2006, 24(36):5652-5657 11 Oakman C, Viale G, Di Leo A: Management of triple negative breastcancerBreast 2010, 19(5):312-21 12 ... proliferative breast carcinoma subtype BreastCancer Res Treat 2006, 98(1):91-8 Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO: Prognostic markers in triple-negative breastcancerCancer ... Targeting CD138 for RIT is attractive since this antigen is associated with an aggressive breastcancer phenotype CD138 is expressed by about 75% of ER-negative forms of breastcancer [39], and...
... management of earlystage invasive breastcancer Curr Probl Surg 2004, 41:877-936 National Comprehensive Cancer Network (NCCN) Clinical Guidelines in Oncology forBreastCancer (V.1.2009) [http:/ ... of the axilla during breastcancersurgery [1-3] The sensitivity of intraoperative frozen section analysis for identifying nodal metastases within SLNs during breastcancersurgery has been reported ... series in which the false negative rate of frozen section analysis for SLN biopsy was 33% for ILC, 25% for IDC, and 30% for all breastcancer cases This particular aspect of Leidenius et al [12] reported...
... receptor positive lymph node negative (ER+LN-) breastcancer Another study validated a predictive score, based on 21 genes, for ER+LN-tamoxifen treated breastcancer [2] These results are encouraging, ... primary breastcancer J Clin Oncol 2006, 24:1665-1671 Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM: Concordance among gene-expressionbased predictors forbreastcancer ... organization, nucleosome assembly Top ranked 17 prognostic genes in ER+ breastcancer as determined by a meta-analysis of three major breastcancer data sets We give the sign of their global average Cox-regression...
... approximately one in five breast cancers is human epidermal growth factor receptor 2/erb-B2 (HER2)positive breast cancers Hormone receptor-positive and HER2-positive breast cancers have highly effective ... targeted treatments available Triple-negative breastcancer (TNBC) accounts for 15% to 20% of breast cancers (Konecny G 14 et al., 2003) Therapy for TNBC is empiric and not based on tumor biology, ... 83 11 Figure 14 HSVtk/GCV and CD/5-FC forbreastcancer therapy mediated by iPSC-NSC 86 Figure 15 Survival analysis of breastcancer receiving HSVtk/GCV or CD/5-FC treatment...
... sponsored the publication of this EDCF Guide to Early Adopters The EDCF GuideforEarly Adopters Contents Foreword Audio for Digital Cinema 14 1.1 The Guide EDCF Technical Module Theatre Systems ... will the huge technological transformation, described in this "EDCF GuideforEarly Adopters", affect the business of distributors and exhibitors? At this earlystage in the migration from analogue ... heavily on existing TV technology and are therefore supported quite well by existing standards 1.1 The Guide Why would the EDCF make a guideforearly adopters? In Europe there have been several...
... of COX inhibitors early, but not late in the infection cycle [15] In conclusion, our results clearly show that COX activity is required for efficient virus replication in vitro early during MHV ... mean ± standard error of mean (n = 6) For statistical analysis a one-way ANOVA with the TukeyKramer test was performed using GraphPad Prism version 3.00 for Windows (GraphPad Software) In all ... activity plays an important role early in the virus infection cycle, at a postbinding step Thus, COX activity might either be required for efficient entry or for an initial step in RNA replication...
... of COX inhibitors early, but not late in the infection cycle [15] In conclusion, our results clearly show that COX activity is required for efficient virus replication in vitro early during MHV ... mean ± standard error of mean (n = 6) For statistical analysis a one-way ANOVA with the TukeyKramer test was performed using GraphPad Prism version 3.00 for Windows (GraphPad Software) In all ... activity plays an important role early in the virus infection cycle, at a postbinding step Thus, COX activity might either be required for efficient entry or for an initial step in RNA replication...
... it very convenient for sick/elderly patients, reduces health care costs and frees up resources for other patients All stage T1-2, N0 lung cancer patients, medically unfit for surgery, received ... Co-morbid conditions have been shown to affect prognosis in earlystage NSCLC [8] Unfortunately, the typical earlystage NSCLC patients referred for curative radiation therapy have grave impairment ... radiation therapy is an attractive option for patients with earlystage nonsmall cell lung cancer (NSCLC) who are not surgical candidates Although primarily appealing for patients with tumors that are...